Peer Review reports
From: CCL-DTI: contributing the contrastive loss in drug–target interaction prediction
| Original Submission | ||
|---|---|---|
| 13 Sep 2023 | Submitted | Original manuscript |
| 28 Sep 2023 | Reviewed | Reviewer Report |
| 19 Oct 2023 | Reviewed | Reviewer Report |
| 6 Nov 2023 | Author responded | Author comments - Parvin Razzaghi |
| 21 Nov 2023 | Reviewed | Reviewer Report |
| 7 Dec 2023 | Reviewed | Reviewer Report |
| 8 Dec 2023 | Author responded | Author comments - Parvin Razzaghi |
| Resubmission - Version 2 | ||
| 6 Nov 2023 | Submitted | Manuscript version 2 |
| 31 Dec 2023 | Reviewed | Reviewer Report |
| 7 Jan 2024 | Author responded | Author comments - Parvin Razzaghi |
| Resubmission - Version 3 | ||
| 7 Jan 2024 | Submitted | Manuscript version 3 |
| 12 Jan 2024 | Reviewed | Reviewer Report |
| 16 Jan 2024 | Author responded | Author comments - Parvin Razzaghi |
| Resubmission - Version 4 | ||
| 16 Jan 2024 | Submitted | Manuscript version 4 |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| 19 Jan 2024 | Author responded | Author comments - Parvin Razzaghi |
| Resubmission - Version 6 | ||
| 19 Jan 2024 | Submitted | Manuscript version 6 |
| Publishing | ||
| 22 Jan 2024 | Editorially accepted | |
| 30 Jan 2024 | Article published | 10.1186/s12859-024-05671-3 |
You can find further information about peer review here.